MicroPort Medical: Endovastec's net profit attributable to the parent company in the first half of the year was approximately 315 million yuan, a year-on-year decrease of 22.03%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, MicroPort Medical announced the performance of Endovastec for the first half of 2025, with revenue of approximately 714 million yuan, a year-on-year decrease of 9.24%; the net profit attributable to the equity holders of Endovastec was approximately 315 million yuan, a year-on-year decrease of 22.03%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments